Member Exclusive INTERVIEW

#TalkingRegMed episode 6: Brexit with Matthew Durdy, Cell and Gene Therapy Catapult

In this episode of #TalkingRegMed, Matthew Durdy, Chief Business Officer, Cell and Gene Therapy Catapult, explains the effect of Brexit on cell therapy development in the UK.

Mar 13, 2018
0
0

Please sign in or register for FREE

No comments yet.